Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Study data from University of Amsterdam provide new insights into adenocarcinoma
February 3rd, 2009
According to recent research published in the journal Annals of Surgical Oncology, "The presence of lymphatic dissemination is an important predictor of survival in esophageal adenocarcinoma (EA). The aim of this study was to discover a prognostic gene expression pro. le for lymphatic dissemination in EA and to identify genes and pathways that provide oncological insight in lymphatic dissemination." "Patients who had lymphatic dissemination (N = 55) were compared with patients without lymphatic dissemination (N = 22). Whole-genome oligonucleotide microarrays were used to evaluate the genetic signature of 77 esophageal cancers. Multiple random validation was used...
Source: Cancer Weekly (2009-02-03)
|
